Small-Molecule-Directed Mpl Signaling Can Complement Growth Factors to Selectively Expand Genetically Modified Cord Blood Cells
Authors:
- 1 January 2003
- journal article
- Published by Oxford University Press (OUP) in Stem Cells
- Vol. 21 (1) , 71-78
Abstract
Efforts toward achieving gene therapy for blood disorders are plagued by low rates of gene transfer into hemopoietic stem cells. Recent studies suggest that this obstacle can be circumvented using selection. One way to achieve selection employs genes that encode receptor-bearing fusion proteins capable of inducing cell growth in response to drugs called chemical inducers of dimerization (CIDs). We have previously shown that genetically modified marrow cells from mice can proliferate for up to a year in culture in response to CID-initiated signals arising from the thrombopoietin receptor (mpl). The sustained growth observed in mouse hemopoietic cells results from an mpl-induced self-renewal of multipotential hemopoietic progenitor cells. In contrast, human hemopoietic cells proliferate only transiently in response to the mpl signal (from differentiation of transduced erythroid and megakaryocytic progenitors), while human myeloid progenitors fail to respond. Here, we show that myeloid progenitors from human cord blood can be induced to proliferate and/or differentiate in response to the mpl signal by providing additional signals via a combination of growth factors. These findings are relevant for the eventual clinical application of CID-regulated cell therapy.Keywords
This publication has 16 references indexed in Scilit:
- Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectorsProceedings of the National Academy of Sciences, 2002
- Receptor specificity in the self-renewal and differentiation of primary multipotential hemopoietic cellsBlood, 2001
- Pharmacologically regulated cell therapyBlood, 2001
- In vivo selection using a cell-growth switchNature Genetics, 2000
- Expansion of genetically modified primary human hemopoietic cells using chemical inducers of dimerizationBlood, 2000
- Optimization of retroviral-mediated gene transfer to human NOD/SCID mouse repopulating cord blood cells through a systematic analysis of protocol variablesExperimental Hematology, 1999
- Transduction of Human CD34 + Cells That Mediate Long-Term Engraftment of NOD/SCID Mice by HIV VectorsScience, 1999
- Targeted expansion of genetically modified bone marrow cellsProceedings of the National Academy of Sciences, 1998
- The role of c‐Mpl ligands in the expansion of cord blood hematopoietic progenitorsStem Cells, 1998
- A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cellsGene Therapy, 1997